Network origin in Adar Makovski Silverstein first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Adar Makovski Silverstein via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| Nottingham Trent University | College/University | Undergraduate Degree | |
| King's College London | College/University | Graduate Degree | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Liverpool | College/University | Undergraduate Degree | |
| Imperial College London | College/University | Doctorate Degree | |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director/Board Member | |
| CommBio Therapeutics Co., Ltd. | Chief Tech/Sci/R&D Officer | ||
| The Hebrew University of Jerusalem | College/University | Graduate Degree | |
| Kwame Nkrumah University of Science & Technology | College/University | Undergraduate Degree | |
| University of Calgary | College/University | Doctorate Degree | |
| University of Zimbabwe | College/University | Doctorate Degree | |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Investment Managers | Corporate Officer/Principal | |
Digital Alpha Advisors LLC
 Digital Alpha Advisors LLC Investment ManagersFinance Digital Alpha Advisors LLC (Digital Alpha Advisors) is a private equity firm founded in 2017 by Rick Shrotri. The firm is headquartered in Henderson, Nevada. | Investment Managers | General Counsel | |
| Colgate University | College/University | Undergraduate Degree | |
| Northwestern University School of Law | College/University | Graduate Degree | |
Accounting Research & Analytics LLC
 Accounting Research & Analytics LLC Investment ManagersFinance Accounting Research & Analytics LLC, do-business-as Center for Financial Research & Analysis (CFRA), is an investment research firm headquartered in New York City. The firm was founded in 1994 and is a subsidiary of CFRA Research, Inc. CFRA provides independent and actionable research and analytics to their global subscribers to improve their investment and business decisions. The firm’s services also include forensic accounting research and analytics that identifies public companies with deteriorating earnings quality; and fundamental research and commentary focused on stocks, ETFs, mutual funds, sectors and industries. | Investment Managers | Private Equity Analyst | |
Kirkland & Ellis LLP
 Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Kirkland & Ellis LLP provides legal services. It counsels clients in litigation, corporate and tax, intellectual property and restructuring matters. The firm offers intellectual property, antitrust and competition, international trade and national security, real estate and tax, benefits and estate planning services. The company was founded in 1909 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Private Equity Analyst | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | President | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| COVANCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pierian Biosciences LLC
 Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Medical/Nursing Services | Corporate Officer/Principal | |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Virginia School of Medicine | College/University | Doctorate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| United States | 21 |
| United Kingdom | 8 |
| China | 2 |
| Israel | 2 |
| Canada | 2 |
Sectoral
| Consumer Services | 16 |
| Health Technology | 11 |
| Commercial Services | 4 |
| Finance | 4 |
| Health Services | 2 |
Operational
| Corporate Officer/Principal | 11 |
| Chief Tech/Sci/R&D Officer | 8 |
| Undergraduate Degree | 7 |
| Doctorate Degree | 4 |
| Director/Board Member | 4 |
Most connected contacts
| Insiders | |
|---|---|
| Abraham Noah Oler | 11 |
| Mark Gelder | 9 |
| Peter Atadja | 7 |
| Trafford Clarke | 5 |
| Meena Arora | 4 |
| Victor Moyo | 3 |
| Michael Saunders | 1 |
- Stock Market
- Insiders
- Adar Makovski Silverstein
- Company connections
